首站-论文投稿智能助手
典型文献
Correlation between CD44 and membrane fluidity—a study on biopsies of high-grade serous ovarian tumor
文献摘要:
The functioning of the cell plasma membrane depends on its lipid and protein compositions[1].Changes in membrane physiochem-ical characteristics,such as fluidity,are associated with normal cellular physiology[2]and tumor malignancy[3].As an extensively distributed cell surface marker,CD44 is implicated in the pathogenesis and progression of many cancerous cells,including ovarian cancer cells[4].A previous study on a cell model indicated that the level of CD44 might be correlated with the fluidity of the plasma membrane[5].However,no study has been reported on either the status of plasma membrane fluidity or the levels of CD44 in human tumors.In the present report,we studied the status of membrane fluidity and the level of CD44 in normal ovary epithelium and stage Ⅲ high-grade serous ovarian cancer(HGSOC),a common epithelial ovarian cancer[6].The main methods are described in Supplementary Data.
文献关键词:
作者姓名:
Jun Shi;Yang Yang;Wei He;Munika Moses;Yi-hua Gu;Ningli Li;Wen Di
作者机构:
Shanghai Institute of Immunology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Department of Obstetrics and Gynecology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Shanghai Institute for Biomedical and Pharmaceutical Technologies,Shanghai 200032,China;Department of Pathology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Institut Pasteur of Shanghai,Chinese Academy of Sciences,Shanghai 200031,China
引用格式:
[1]Jun Shi;Yang Yang;Wei He;Munika Moses;Yi-hua Gu;Ningli Li;Wen Di-.Correlation between CD44 and membrane fluidity—a study on biopsies of high-grade serous ovarian tumor)[J].生物化学与生物物理学报(英文版),2022(12):1928-1930
A类:
physiochem
B类:
Correlation,between,CD44,membrane,fluidity,study,biopsies,high,grade,serous,ovarian,functioning,plasma,depends,its,lipid,protein,compositions,Changes,ical,characteristics,such,are,associated,normal,cellular,physiology,malignancy,extensively,distributed,surface,marker,implicated,pathogenesis,progression,many,cancerous,cells,including,previous,model,indicated,that,might,correlated,However,has,been,reported,either,status,levels,human,tumors,In,present,studied,ovary,epithelium,stage,HGSOC,common,epithelial,main,methods,described,Supplementary,Data
AB值:
0.529299
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu;Dongqing Zuo;Jie Chen;Zhigang Liu;Zhuo Wang;Liu Yang;Qihui Shi;Yingqi Hua-Shanghai Bone Tumor Institute and Department of Orthopedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200080,China;Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Center for Systems Biomedicine,Shanghai Jiao Tong University,Shanghai 200240,China;Shanghai Key Laboratory of Medical Epigenetics and the International Co-laboratory of Medical Epigenetics and Metabolism(MOST),Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer(SMHC)and Institute of Fudan-Minhang Academic Health System,Minhang Hospital,Fudan University,Shanghai 201199,China;Shanghai Engineering Research Center of Biomedical Analysis Reagents,Shanghai 201203,China
The mini player with diverse functions:extracellular vesicles in cell biology,disease,and therapeutics
Abhimanyu Thakur;Xiaoshan Ke;Ya-Wen Chen;Pedram Motalllebnejad;Kui Zhang;Qizhou Lian;Huanhuan Joyce Chen-The Pritzker School of Molecular Engineering,The University of Chicago,Chicago,Illinois,USA;The Ben May Department for Cancer Research,The University of Chicago,Chicago,Illinois,USA;Division of Pulmonary,Critical Care and Sleep Medicine,Department of Medicine,Keck School of Medicine,Hastings Center for Pulmonary Research,University of Southern California,Los Angeles,CA 90089,USA;Department of Stem Cell Biology and Regenerative Biology,Keck School of Medicine,University of Southern California,Los Angeles,CA 90089,USA;Department of Medicine,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pok Fu Lam,Hong Kong;Prenatal Diagnostic Center and Cord Blood Bank,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou,China;HKUMed Laboratory of Cellular Therapeutics,the University of Hong Kong,Pok Fu Lam,Hong Kong
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。